Life Sciences: Biotech

Companies thriving on public's anxiety

Fears spur sales of biodefense drugs

By Ross Kerber

Globe Staff / March 22, 2004

E-mail|
Print|
Reprints|
|

Text size – +

Some drug makers don't mind a little fear in the market. Take, for instance, the experience of Anbex Inc. of New York, which sells potassium iodide tablets meant to protect the thyroid gland from absorbing radiation. Sales rose steadily between the attacks of Sept. 11 and the invasion of Iraq, amid fears of attacks on domestic nuclear power plants. But ... (Full Article: 957 Words)